ColgatePalmolive (CL)
(Delayed Data from NYSE)
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $97.70 +1.21 (1.25%) 8:20 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $97.70 +1.21 (1.25%) 8:20 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Zacks News
Here's Why Procter & Gamble is a Hot Investment Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from ongoing initiatives to improve productivity. Also, the company is focused on product improvement, packaging and marketing initiatives and cost-saving plans.
Church & Dwight Likely to Keep Gaining on Solid Sales Trend
by Zacks Equity Research
Church & Dwight's (CHD) sales are gaining from continued category growth and healthy market share gains. The company's consumer international business has long been contributing to the top line.
Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock
by Zacks Equity Research
Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.
Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y
by Zacks Equity Research
Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.
Colgate-Palmolive (CL) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of -1.37% and -0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Colgate-Palmolive (CL) Might Surprise This Earnings Season
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Buy 5 High-Flying Stocks Ahead of Q2 Earnings This Week
by Nalak Das
It will be prudent to invest in stocks that are likely to beat earnings estimates in the second quarter this week.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Things You Need to Know Before FEMSA's (FMX) Q2 Earnings
by Zacks Equity Research
FEMSA's (FMX) second-quarter 2019 results are likely to be impacted by ongoing cost headwinds, which should continue to hurt margins. However, its growth efforts might provide some respite.
Check Out Colgate's (CL) Probability to Beat in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) growth efforts indicate that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.
Can Colgate-Palmolive (CL) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Colgate (CL) to Expand Skin Care Range With Filorga Buyout
by Zacks Equity Research
Colgate (CL) to expand the personal care portfolio with the acquisition of skin care business of France-based Filorga.
Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins
by Zacks Equity Research
Colgate's (CL) strong surprise trend, higher pricing, strong innovation and expansion efforts bode well. However, high input costs and currency headwinds concerns.
Soap & Cleaning Materials Industry Outlook Upbeat on New Products
by Rajani Lohia
The FMCG space is likely to gain from investment in brands, innovation, cost-containment and pricing actions. However, its struggles against higher raw material and transportation costs continue.
Procter & Gamble Moves Up the Charts: Will Growth Continue?
by Zacks Equity Research
Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?
by Zacks Equity Research
Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.
Will Archer Daniels' Strategic Growth Efforts Drive Stock?
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions segment is concerning. Nevertheless, the company's growth efforts such as the Readiness program are commendable.
Here's Why Colgate (CL) Deserves a Place in Your Portfolio
by Zacks Equity Research
Colgate (CL) exhibits strong surprise trend, owing to accelerated investments in brands, higher pricing and strong innovation along with expansion in new markets and channels.
Factors Likely to Influence Brown-Forman's (BF.B) Q4 Earnings
by Zacks Equity Research
Brown-Forman's (BF.B) Q4 results are likely to benefit from robust brand portfolio. However, tariff-related costs are hurting underlying net sales and gross margin.
Colgate-Palmolive (CL) Up 3.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Procter & Gamble (PG) Surges 47% in a Year: More Room to Run?
by Zacks Equity Research
Procter & Gamble (PG) stock reflects immense growth potential, backed by ongoing initiatives to improve productivity. However, strained margins and currency headwinds remain deterrents.
Here's Why Colgate-Palmolive (CL) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Colgate-Palmolive (CL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Church & Dwight (CHD) Q1 Earnings Beat, Organic Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) earnings and sales improve in Q1. Management raises net sales view, considering the buyout of FLAWLESS.